All results
2 results
-
Eliminating Total Body Irradiation (TBI) from Acute Lymphoblastic Leukemia (ALL) Treatment
This study will evaluate the use of non* TBI (total body irradiation) conditioning for B-ALL patients with low risk of relapse as defined by absence of NGS-MRD…
- Ages
- 1 Year - 25 Years
- Sexes
- All
-
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mix
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia…
- Ages
- 1 Year - 25 Years
- Sexes
- All